Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-18

Clinical Trial Update: Intraperitoneal Dexamethasone, Dexmedetomidine, and Dexamethasone-Dexmedetomidine Combination on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intraperitoneal dexamethasone, dexmedetomidine, and their combination for prevention of postoperative nausea and vomiting afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)
  • Dexamethasone-Dexmedetomidine Combination (dexamethasone-dexmedetomidine combination)
  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Al-Azhar University | Conditions: Laparoscopic Cholecystectomy, Postoperative Nausea and Vomiting | Phase 3 | Status: COMPLETED